Dianomi Therapeutics Overview
- Year Founded
-
2017

- Status
-
Out of Business
- Employees
-
7

- Latest Deal Type
-
Out of Business
Dianomi Therapeutics General Information
Description
Owner and operator of a biopharmaceutical company focused on developing treatments for inflammatory diseases, initially targeting osteoarthritis. The company's mineral coated microparticle (MCM) technology has the ability to provide sustained release delivery of active biologics, an issue many traditional drug delivery systems struggle with, enabling patients to have improved, sustained-release delivery of active biologics.
Contact Information
Website
www.dianomitx.comCorporate Office
- 504 South Rosa Road
- Suite 200
- Madison, WI 53719
- United States
Corporate Office
- 504 South Rosa Road
- Suite 200
- Madison, WI 53719
- United States
Dianomi Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Out of Business | 21-Aug-2022 | Completed | Out of Business | |||
4. Early Stage VC (Series A) | 09-Feb-2021 | Completed | Pre-Clinical Trials | |||
3. Angel (individual) | Completed | Pre-Clinical Trials | ||||
2. Early Stage VC | 04-Feb-2019 | $3M | $3.19M | Completed | Pre-Clinical Trials | |
1. Angel (individual) | 25-Jan-2019 | $185K | $185K | Completed | Pre-Clinical Trials |
Dianomi Therapeutics Comparisons
Industry
Financing
Details
Dianomi Therapeutics Competitors (148)
One of Dianomi Therapeutics’s 148 competitors is Cullgen, a Venture Capital-Backed company based in San Diego, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Cullgen | Venture Capital-Backed | San Diego, CA | ||||
AbogenBio | Venture Capital-Backed | Suzhou, China | ||||
Shuttle Pharmaceuticals | Formerly VC-backed | Gaithersburg, MD | ||||
Scorpion Therapeutics | Venture Capital-Backed | Boston, MA | ||||
Centrexion Therapeutics | Venture Capital-Backed | Boston, MA |
Dianomi Therapeutics Patents
Dianomi Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20190358344-A1 | Mineral coated microparticles for sustained delivery of steroids | Inactive | 23-May-2018 |
Dianomi Therapeutics Signals
Dianomi Therapeutics FAQs
-
When was Dianomi Therapeutics founded?
Dianomi Therapeutics was founded in 2017.
-
Where is Dianomi Therapeutics headquartered?
Dianomi Therapeutics is headquartered in Madison, WI.
-
What is the size of Dianomi Therapeutics?
Dianomi Therapeutics has 7 total employees.
-
What industry is Dianomi Therapeutics in?
Dianomi Therapeutics’s primary industry is Biotechnology.
-
Is Dianomi Therapeutics a private or public company?
Dianomi Therapeutics is a Private company.
-
What is Dianomi Therapeutics’s current revenue?
The current revenue for Dianomi Therapeutics is
. -
How much funding has Dianomi Therapeutics raised over time?
Dianomi Therapeutics has raised $10.8M.
-
Who are Dianomi Therapeutics’s competitors?
Cullgen, AbogenBio, Shuttle Pharmaceuticals, Scorpion Therapeutics, and Centrexion Therapeutics are some of the 148 competitors of Dianomi Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »